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Development of a Biomedical Innovation Economy-Panama 
 




In this study we consider the progress toward the development of innovation incubators within the Central American 
country of Panama. We attempt to identify the extent to which Panama, as a developing country with a small market size, 
has recognized the importance of technology and innovation in its efforts to build a sustainable economy. We examined 
the “Triple Helix” government-academia-industry model (Etzkowitz, 2008), and applied it to the bioscience sector, while 
also incorporating the role of foreign collaborators. By reinforcing and maintaining synergies among all stakeholders, while 
also concentrating resources in the areas of strengths and increasing R&D expenditures, Panama could become a key re-
gional player in the bioscience sector. Examples of cooperative research innovation are highlighted, and suggestions are 
made to enhance their commercialization potential. 
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Independence gained from Gran Columbia was realized 
in 1903, but one could argue that the history of modern 
Panama started more recently. Two recent events sig-
nificantly shaped present day Panama, the United States 
invasion of 1989, and the hand-over by the United 
States of the canal and with it billions of dollars worth of 
land and infrastructure (Pérez, 2000). The withdrawal of 
the remaining US military presence in the year 2000 
allowed Panama to gain full sovereignty of its territories, 
and make independent decisions about the management 
of the Canal and the surrounding land. Today, Panama 
sees itself as an important logistical hub, keen on devel-
oping a foreign policy agenda with a number of global 
players. Even after the US-led invasion and disputes over 
military base rights, Panamanians retain a favorable view 
of the United States, and seek to strengthen their trad-
ing ties (Furlong, 2000). The relationship with Japan as 
the second largest trading partner is likely to continue 
as Panama looks to increase importation of Japanese 
technological goods. Other Asians countries such as 
China, Taiwan and Korea are increasing their level of 
investment and trade with Panama. The Colon Free 
Trade Zone is the largest of its kind in the Western 
Hemisphere, as it handles more than US$14 billion in 
imports and re-exports each year. 
Today’s economy is largely based on transportation and 
logistics, financials, insurance, exportation of goods and 
services, and tourism comprising more than 80% of its 
productive output. Panama has recently enjoyed a pe-
riod of substantial economic stability, with annual GDP 
growth of more than 8% over the last three years (U.S. 
Dept. of State, 2009). In an effort to build a diversified 
economy, a national strategy has been formulated to 
encourage science, technology and innovation. To this 
end, the government of Panama has prioritized science, 
technology and innovation for its long term growth. The 
presence of good infrastructure including transporta-
tion, electrical power generation, clean water, and in-
ternet connectivity within Panama City, and its central 
geographic location between North and South America, 
make it an attractive location for foreign investment. 
However, weaknesses have been acknowledged in the 
areas of innovation and higher education training (Cimo-
li, 2005). Many developing countries have recognized the 
importance of technology and innovation in their efforts 
to build sustainable economies. In this study we ex-
amined the potential opportunities for bioscience inno-
vations and the barriers that might exist. 
1. Data Collection 
To get a more complete perspective of the innovative 
bioscience space in Panama, three main data sources 
were utilized for this study. We conducted personal 
interviews with individuals from the government, aca-
demia, technology park and private companies. Also, 
questionnaires were distributed regarding organizational 
interconnectivity and support for commercialization in 
Panama. Finally, traditional reference data were utilized 
to provide historical context and analysis within this 
space. 
2. Economic Agents 
Private companies or institutes that undertake research 
and development to generate products or services play 
an important role in a knowledge-based economy (Pow-
ers & Powers, 1988). They serve not only to sell the 
goods and services of their labor force, but also to em-
ploy graduates of the universities. Locally or regionally 
generated diagnostic services, medicines and medical 
devices, as well as improvement in agricultural technol-
ogies, may present an attractive economic alternative to 
the importation of such products from large developed 
countries. For the bioscience sectors, health and agricul-
ture-related products and services additionally contri-
bute to the improvement in quality of life for the 
population (Cooke, 2007). The decision process for 
students in choosing an area of concentration is influ-
enced not only by their intrinsic interests, but also by 
their exposure to external influences. The local pres-
ence of economic agents known to employ students 
impacts their choice of study.  
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Although there are a hand-full of innovative bioscience 
companies in Panama, only a few are a result of solely 
Panamanian innovation efforts. Several Clinical Research 
Organizations (CROs) have operations in Panama and 
they include: Health Research International of the Uni-
versity of South Florida, Quintiles, a CRO based in 
North Carolina, and LaTAM Mo Clinical Research, a US-
Columbian venture. The Institute of Advanced Scientific 
Investigations and High Technology Services (INDICA-
SAT) operates as a non-profit government research 
institute concentrating on medical-related local issues, 
such as infectious diseases. INDICASAT also serves as a 
regional CRO for pharmaceutical companies (eg. Glaxo 
Smith Kline), in human papilloma virus vaccines. The 
current trend towards establishment of clinical trials 
organizations within Panama is likely to continue due to 
the skilled medical personnel, a track record of previous 
FDA approved clinical trials, and reduced exposure to 
medication among the population as compared with 
developed countries. 
In addition to CROs, several small international bios-
cience-focused companies have a presence in Panama. 
The Venezuela-Japanese-American joint-venture nano-
tech company, Nano Dispersion Technologies, develops 
dispersion fluids-breaking particles to a nanometric size.  
This technology may be applied to multiple industries 
ranging from oil and bio-fuels to cosmetics. With pas-
sage of the recent laws allowing research and therapeu-
tic treatment using stem cells, two foreign companies 
have developed a presence within Panama. MediStem, 
which has facilities in the US and Costa Rica, focuses on 
discovery, development and commercialization of tech-
nologies related to adult stem cell extraction and mani-
pulation for use in treating inflammatory and 
degenerative diseases. The Chinese company Beike, 
which also has operations in Thailand and Europe, has 
treated more than 2000 patients with umbilical cord 
stem cell injection principally for neurodegenerative 
diseases. Natural Control Corporation is an agriculture 
and insecticide company, which has been in existence 
for 40 years in Columbia, and now also has a presence 
in Panama. The business focus is on the improvement of 
output of mainly agricultural products, which have 
yielded revenues with the government as its principle 
client.  
As bioscience innovation can be very capital intensive, it 
has the potential of not only large financial rewards but 
also the development of societal good (Cooke, 2007). 
This being the case, a large risk of failure exists for over-
ly ambitious projects which are not gauged appropriate-
ly. Large multinational companies will take a calculated 
risk of entry based on a variety of factors such as tax 
incentives, trade tariffs, existing skilled labor force, infra-
structure, and regional demand for their goods and ser-
vices. Market entry for small organizations with little 
capital will need to consider these points, but work 
from the perspective of a short-term revenue model. 
The success of economic agents will rely on the ability 
of organizations to capitalize on local and regional 
strengths and build stakeholder interest in local and 
foreign markets (Brown & Duguid, 2002; Gal, 2003). 
Building a local presence in addition to establishing for-
eign partnerships or collaborations with universities and 
private companies will reduce some risks inherent in 
starting of new ventures. Also, the importation of tech-
nical expertise, even on a temporary basis, will be criti-
cal to adequately train local students to become future 
employees. This will have the added advantage of rapid 
adaptation of innovative technologies and become a 
starting point for increased funding from international 
funding agencies. For a country such as Panama with a 
total market size of 3.3 million people, economic agents 
will be wise to pitch their goods and services to address 
local needs but also the global market. For example, 
services such as DNA-based disease diagnosis may find 
an adequate local market for their services, but non-
repeat use therapies may find the Panamanian market 
too small for sustainability. Nevertheless, even those 
bioscience innovation projects that consider the larger 
regional market and near-term revenue have the oppor-
tunity for sustainability. 
A great promise for bioscience-related enterprise gen-
eration within Panama revolves around clinical trial ac-
J. Technol. Manag. Innov. 2009, Volume 4, Issue 2 
24 
ISSN: 0718-2724. (http://www.jotmi.org) 
Journal of Technology Management & Innoovation © Universidad Alberto Hurtado, Facultad de Economía y Negocios 
 
 
tivities. The establishment of a standardized health care 
facilities and low cost of medical care have encouraged 
CROs to enter emerging markets. Central and South 
America combined form a regional block with a total 
population of 562 million. From this perspective the 
region will become of greater importance to the phar-
maceutical industry. From the standpoint of clinical tri-
als, low cost is a driving force, as are the relative naïve 
levels of exposure to medicines by the population at 
large (Shah, 2003; Getz, 2006). For countries such as 
Panama, the overall perception of clinical trial quality by 
regulatory agencies such as the FDA remains to be de-
termined.  
3. Academics 
Emphasis in Panama has been placed on increasing the 
enrollment of students in university level education. 
From 1970 to 2000, university level education among 
scientific and technologically active employees has 
grown from 12% to 20% during this time frame (Villavi-
cencio and Chiapa, 2006), yet only 0.5% of the econom-
ically active population is involved in science and 
technology as a profession. Traditionally, academic in-
terests in biosciences have not been strong, with the 
exception of medicine and forensics. Given the recog-
nized strengths of Panama’s biologically-rich environ-
ment and the growing sector engaged in medical 
services, mechanisms are being put in place to increase 
the student population trained in these areas of speciali-
zation. 
The University of Panama (UP) which was founded in 
1935, has a student population of approximately 74,000. 
UP being the largest university system in the country 
has developed a number of bioscience related centers, 
which serve as areas of study concentration. The UP 
offers a Master’s degree program in biological sciences 
with four concentrations: 1) genetics and molecular bi-
ology, 2) zoology, 3) plants science, and 4) marine biolo-
gy. At present UP does not offer a PhD program in 
biological sciences but instead sends promising students 
to conduct thesis research at the University of Granada 
in Spain. There is a clear recognition among the faculty 
of the importance of commercialization of discovery. UP 
scientists continue to conduct experimental analysis of 
plant extracts from the surrounding jungles for biologi-
cal activities of therapeutic benefit. Funding has been 
granted through the NIH for these studies, and collabo-
rations with US universities continue. Patent protection 
for these discoveries has primarily been granted through 
the United States Patent and Trademark Office. The 
General Office for Registration of Industrial Property 
(DIGERPI) handles local intellectual property issues and 
falls under the guidance of the Ministry of Commerce 
and Industry.  
The UP in an effort to facilitate commercialization of 
discovery has newly created the office of Transference 
of Research Results (OTRI in Spanish) in the City of 
Knowledge. This office functions as a link between UP 
and private sector companies. In this arrangement the 
University offers guidance with respect to proper eco-
nomic incentives for the scientists involved in advancing 
their discoveries to commercialization. Also, UP has 
organized and participated in several workshops on in-
tellectual property and patents, and recently, it has set 
up a database containing information regarding patents 
and intellectual property to assist researchers.  
Other institutions in Panama have developed programs 
in biosciences. The Technological University of Panama 
offers a biotechnology study program with applications 
to the agricultural industry.  
4. Government 
The ministry of science and technology (SENACYT) has 
taken a very proactive role in the encouragement and 
development of a knowledge-based sector. It is well 
recognized that the economic competitiveness of a na-
tion is linked with knowledge development (Arocena & 
Sutz, 2000). To this effect, SENACYT has coordinated 
the formulation of a National Strategic Plan for the De-
velopment of Science, Technology and Innovation for 
the years 2006-2010. The aim is to provide a framework 
to guide the growth of a knowledge-based sector in 
Panama with respect to an array of science-related in-
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dustries. As for the biosciences, recommended steps of 
action have been brought forth and include the forma-
tion of a national bioscience commission to provide 
guidance and policy oversight with the aim of streng-
thening capacity in technology and human resources to 
support sustainable development. Additional recom-
mendations include the formation of a funding agency 
for biosciences, the development of human resources to 
meet the science and technology demands of the coun-
try, and further development of a five-year plan to 
broaden research in biosciences.  
To date, SENACYT has already incorporated a number 
of aspects of the Strategic Plan. Since 2004, SENACYT 
has funded 280 scholarships ranging from the Bachelors 
degree level through to the PhD and Post-doctoral lev-
el. Of these, approximately 150 were for doctoral or 
post-doctoral level studies in foreign universities. In 
2008 alone, Panama has invested $8 million in scholar-
ships. Scientific funding has also been made available for 
research in areas including biosciences, agriculture, tour-
ism, logistics and transportation through an open grant-
ing process that is reviewed by an international board, 
and where emphasis is being placed on collaborative 
efforts that tie into the strengths of the country. The 
Open Calls or grants are available to both public and 
private entities. SENACYT has directed over $10M in 
public funding toward projects and activities in innova-
tion as well as R&D where both the private and go-
vernmental sector have been involved in conjunction 
with international collaborators. Although government 
constitutes the largest domestic funding source, financ-
ing from foreign sources represented 71% of all R&D 
spending in 2002 (OECD Paris, 2004). Additionally, the 
National Research System (Sistema Nacional de Investi-
gacion-SNI) was created in December 14, 2007 (Law 
54), with the objective of providing policy direction and 
promoting scientific and technological research through 
economic incentives.  
The favorable Panamanian tax incentives, high-level of 
computer connectivity and strong economic growth 
imply that basic elements to encourage growth in tech-
nological output are present. To this effect, the devel-
opment of the Technology Park within the City of 
Knowledge lends itself for innovation clustering. The 
presence of international NGOs and collaborative edu-
cation programs with Louisiana State University and 
Florida State University may be a base for capacity build-
ing. However, improvements are needed in local science 
education and research training, strengthening public-
private collaborations, intellectual property filings and 
job creation. 
As the operating budget for INDICASAT is supported 
by the government, it has several revenue-generating 
programs in place that consist of contracts or collabora-
tive agreements with foreign universities or companies. 
One of INDICASAT’s collaborations links efforts of the 
University of Panama and the Smithsonian Tropical Re-
search Institute to prospect for biologically active fac-
tors from natural sources, which falls under the 
International Cooperative Biodiversity Groups (ICBG) 
program. Bioassays are used to test extracts for poten-
tial therapeutic relevance, such as inhibition of infectious 
disease replication or as anti-cancer agents. Further 
preclinical testing of extracts is performed in collabora-
tion with universities in the United States. INDICASAT 
is staffed by Panamanians, as well as foreign scientists 
trained either in foreign or local universities.  
The public health institution, Gorgas Commemorative 
Institute of Health Studies (Instituto Conmemorativo 
Gorgas de Estudios de la Salud: República de Panama), 
founded in 1921, performs scientific research in health, 
epidemiology, and environment. With a generous grant 
from the Global Fund, Gorgas is building a state-of-the-
art facility to help develop a biomedical training program 
and reference diagnostic laboratory for the region. Gor-
gas additionally collaborates with Johns Hopkins Medical 
International in the areas of HIV, women’s health, and 
medical and public health education, as it trains local 
talent in biomedical, laboratory, clinical and epidemi-
ologic research. In operation since 2006, the Hospital 
Punta Pacifica is currently being managed by Johns 
Hopkins Medicine International. Besides providing clini-
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cal and diagnostic care, it also offers training opportuni-
ties for physicians.  
The Smithsonian Institute for Tropical Research (STRI), 
which is a US government agency based in Panama, is a 
world class research institute which focuses on evolu-
tionary biology and ecology. Its involvement in basic 
ecological research and characterization of plant and 
animal species diversity, set the groundwork for the 
ICBG program mentioned above. This program has re-
ceived international funding from the National Institutes 
of Health, the US National Science Foundation, and the 
US Department of Agriculture (Rosenthal and Katz, 
2004; Kursar, 2007). The STRI, which employs approx-
imately 40 permanent international staff scientists, con-
ducts some of the ICBG research jointly with UP and 
INDICASAT.  
5. Synergistic Coordination 
To develop a knowledge-based bioscience sector in a 
small market such as Panama, a synergistic coordination 
among various stakeholders will be needed to streng-
then the sector as a whole (Figure 1). Sectors based on 
knowledge-driven innovation and commercialization of 
discoveries as a means of stimulating economic growth, 
have been characterized in the “Triple Helix” model 
(Etzkowitz, 2008). This model incorporates policy-
driven initiatives that promote the interaction between 
government, academia, and industry. The government of 
Panama plays a significant role in making available the 
regulatory guidance, infrastructure, and public financing 
for innovative projects. The greatest benefactors thus 
far have been academic and non-profit research insti-
tutes, but private companies with innovative programs 
may benefit as well. While Panamanian universities place 
emphasis on teaching, they are constrained with regard 
to pushing innovative research agendas forward. The 
importance of training students to become productive 
members of the knowledge-based labor force is of great 
interest when trying to encourage bioscience develop-
ment to prosper (Wemmer, 1993). Companies can aid 
in this process by incorporating promising students into 
internship programs to prepare them for careers in the 
private sector. Because a majority of bioscience R&D-
dependent businesses have long cycles before they gen-
erate revenues, they tend to be initially dependent on 
private financing groups. A return on investment in bi-
oscience innovation projects has traditionally come 
from buy-outs, stock exchange listings, or large-scale 
growth through sales of the organization’s goods and 
services (Hall, 2002). When innovative enterprises seek 
private financing, two issues have to be addressed above 
all: a reasonable chance of success and a viable exit 
strategy for the investment. Once successful precedents 
are created on the market, financiers become more 
involved, and the sector will grow more rapidly. An in-
crease in science capacity should also lead to job crea-
tion and generation of new products, which will 
ultimately serve the government’s interests in growing 
the economy.  
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Figure 1. Interdependence and strengthening of the bioscience innovation sector with foreign entities. 
For smaller developing countries, developed foreign 
markets play an important role in the sustainability of 
sectors such as the biosciences, primarily because of 
their large customer base, but also because they can be 
a source of readily transferable technologies (OECD; 
Bologna, 2000). To date, the main strength of Panama-
nian biosciences has been in the sourcing of biologically 
diverse specimens and activities related to clinical re-
search, which form a foundation for foreign entities to 
pursue future academic and business endeavors. Indeed, 
increased interests in global health on the part of uni-
versities from developed nations are being fueled by 
emerging funding sources such as the Bill & Melinda 
Gates Foundation, or the Global Fund. Also, greater 
public interest in climate change concerns may lead to 
increased funding and more “North-South” collabora-
tions on biodiversity projects (Porter, 2008). Incentives 
by local governments, such as grant availability and tax-
free status for innovative economic projects, should 
help spur foreign involvement.  
6. Barriers 
For purposes of recommending a model for Panama 
where virtuous cycles of synergistic coordination are 
adapted, we recognize that all stakeholders need to 
have a vested interest in the effort (Etzkowitz, 2008). If 
expectations are not met by any one of the stakehold-
ers involved, these linkages will deteriorate and the col-
laborative efforts will not be sustained over longer 
periods of time. In Panama, we have identified some 
weaknesses in the linking of local labor force with inno-
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vative enterprises, both local and foreign. Although 
there seems to be a growing number of qualified scien-
tists, their ability to maintain a high-level of innovation 
through employment remains challenging. Although SE-
NACYT has vastly invested in scholarships, the funding 
has gone in large part to cover graduate and post-
doctoral training of students abroad. The creation of 
local jobs which utilize the innovative capacity in sup-
port of a qualified scientific labor force, is necessary 
when trying to either repatriate Panamanian scientists 
from abroad or retain them in Panama. Without the 
necessary domestic infrastructure and future employ-
ment opportunities, the risk of losing these newly 
trained scientists to foreign markets is very high. In this 
regard, we suggest a more significant investment in local 
academic research as an incentive to bring foreign-
trained Panamanian scientists home. Equally important 
we consider the investment in local scientific training in 
the area of applied research, with the aim of creating 
new capacity for the development of bioscience-related 
products and services in the private sector.  
Traditionally, academics from Latin America have felt a 
certain level of unease with applied research, question-
ing whether for-profit research is likely to compromise 
scientific integrity (Arocena & Sutz, 2000). Although this 
sentiment is not universal (Bok, 2003), the perception of 
this division between pure and applied research acts as a 
barrier in the formation of cooperative relationships 
between universities and industries. When trying to 
create the synergy between the private sector and the 
academic setting, it is necessary that some academic 
researchers understand not only the path from inquiry 
to discovery, but also to commercialization (Etzkowitz, 
2004). This knowledge and exposure may lead to a 
more seamless adaptation of products to the market. A 
balance among stakeholders can only be reached when a 
gradation of basic and applied research is performed in 
the universities and when it can be utilized by industrial 
partners. 
To drive innovation in Panama, we found that more 
efforts need to be directed toward achieving a critical 
mass of qualified researchers and business leaders. Ac-
cording to the Global Competitiveness Index, Panama’s 
level of capacity for innovation remains challenged. One 
of the identified weaknesses has been the relatively low 
availability of scientists and engineers within the popula-
tion (2.3 for every 10,000 inhabitants, in Cimoli, 2005). 
By comparison, Costa Rica and Uruguay have had 3 and 
5 times, respectively, as many individuals engaged in 
science and technology. Among the number of Panama-
nian scientists with appropriate training, only a few have 
dedicated themselves to research only. Faculty members 
at universities have been principally promoted through 
their teaching efforts, with little emphasis placed on re-
search. Recognizing this weakness, SENACYT has in-
vested $5 million in 2007, and $8 million in 2008 in 
scholarship programs for local talent to pursue their 
graduate and post-doctoral training, thus addressing one 
of the needs of the Panamanian innovation sector.  
A knowledge-based sector that relies on biomedical 
advances must not only have qualified human resources, 
but also highly specialized equipment. The high cost of 
technically specialized equipment due to small market 
demand strains capacity building. In particular, reliance 
on equipment purchases through high income countries 
such as the United States drives the prices very high and 
does not allow for equal access to these resources. As 
distributors lack the incentive to enter the Panamanian 
market because of low demand, in the absence of com-
petition, prices for equipment and supplies may be con-
trolled by a sole distributor. Additionally, Panama’s small 
market size currently contributes to inflated cost of 
equipment maintenance and repair due to a limited 
supply of qualified technical service personnel. Given the 
appropriate incentives, influx of new technologies will 
help in solving these shortages.  
7. Recommendations 
With the vast potential in biosciences, countries of small 
market size would be best served to examine their in-
herent strengths and build capacity around those areas 
(Brown & Dugaid, 2002; Gal, 2003). Success of complex 
scientific endeavors relies on geographically concen-
trated technology platform building capabilities, whether 
in developed or developing countries (Mytelka, 2006). In 
Panama, two dominant bioscience areas are perceived 
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to be the sector’s strengths, biodiversity research and 
medical-related services. To expedite the formation of 
the bioscience innovation sector, emphasis should be 
placed on the synergistic coordination in these two 
areas, and resources should be concentrated on building 
and promoting these areas within a regional framework. 
Panama could leverage these strengths to deepen and 
extend the international network of collaborators and 
co-investigators, which would result in a temporary or 
long-term recruitment of technically skilled talent.  
Mutually beneficial cooperation with foreign universities 
or economic agents is more likely achieved when there 
is a full awareness of opportunities present in the coun-
try (OECD; Bologna, 2000). In this study, we have hig-
hlighted some of the foreign bioscience companies that 
have gained presence in Panama. Further promotional 
campaigns are needed to bring attention to the positive 
attributes of Panama’s developing knowledge-based sec-
tor. Enhanced interaction through scientific conference 
attendance or hosting of such conferences would in-
crease international exposure and ultimately lead to 
more international collaborations. Sustained collabora-
tions over time between students returning from 
abroad and their international host universities will fos-
ter a greater network of interactions. 
The more clearly the competitive strengths of the coun-
try are articulated, the greater will be the involvement 
of foreign collaborators. As highlighted by Porter 
(1998), competition within industries is not restricted 
by national boundaries. Rather, the development of a 
sustainable knowledge-based industry must be globally 
competitive. Because of the already existing, highly spe-
cialized, scientific international work force readily relo-
cating between developed countries for work 
opportunities, the challenge for the developing countries 
will be to present comparable work opportunities in 
order to attract such a qualified global work force. A 
successful precedent exists in Panama with projects 
conducted by the Smithsonian Institute for Tropical Re-
search, and the International Cooperative Biodiversity 
Groups (ICBG), programs which have greatly appealed 
to international scientists working in the area of sys-
tems-related ecology, evolution, and biodiversity. Suc-
cesses of similar programs are dependent on sustained 
funding together with a continued research interest on 
the part of international collaborators. With the inter-
nationally recognized importance of biodiversity protec-
tion (Beattie, 2005), we can anticipate a growing interest 
in one of Panama’s competitive areas of research – bio-
prospecting. If the level of competitiveness is to in-
crease, the level of R&D spending as percentage of GDP 
has to be higher than what is has been (below 0.5%). 
Financing thus far has been provided by the government 
and foreign sources (Cimoli, 2005). Robust knowledge-
based economies devote as much as 3% of their GDP to 
R&D, which correlates with strong higher education 
enrollments (Arocena & Sutz, 2000). For example, over 
the last 20 years, South Korea raised their level of fi-
nancing for R&D from 0.4% to 2.9% of the GDP, and 
correlatively, higher education levels increased from 
10% to 60% during this time frame (Kim, 1993). The 
higher the R&D spending as a percentage of GDP, the 
more likely it is that Panama will successfully develop a 
viable knowledge-based economy.  
We can anticipate that a steadily increasing number of 
students attending universities and seeking scientific 
training abroad through SENACYT programs will posi-
tively impact the Panamanian knowledge base. In order 
to provide an environment for discovery and innovation, 
well equipped laboratory infrastructure as well as 
sources of funding for material supplies, have to be pro-
vided to ensure research completion, publication and 
patent filings. The perception that specialized research 
will not have the infrastructure or critical mass of hu-
man resources to make scientific advancements, will 
keep students from returning. As an alternative, the 
development of local programs providing final phase of 
scientific training for Panamanian students studying 
abroad may be a good way to ensure their return, the-
reby preventing some of the country’s brain drain. The 
training processes could involve local supervisory scien-
tists in coordination with international site scientists. 
The goal of these collaborations would be to frame al-
liance strategy, coupling research training with specific 
aims that focus on local strengths in the bioscience sec-
tor. Improved human resource capabilities and in-
creased local research capacity will foster deeper 
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interest of international academics and economic agents, 
and it may lead to the framing of alliance strategies be-
tween local experts and foreign companies. 
In addition to academic-based training programs, bios-
cience specialization fields need to be strengthened by 
aligning companies in the sector to become the down-
stream employers for graduating students. In the case of 
Brazil, the initial build-up of the biotechnology sector 
concentrated heavily on generic drug production (Re-
zaie, 2008). Although Brazil produced a large number of 
trained researchers from its academic institutions, this 
potential labor force was not in great demand because 
the skill sets did not match private company interests 
(Marques, 2007). To avoid this pitfall, creating intern-
ships in the private sector would enhance the skill set of 
students, while at the same time, provide targeted train-
ing opportunities for a future labor force. Internships 
function to train and qualify students for the workforce, 
while providing companies with a screening mechanism 
for future employees. 
We additionally found that one of the components of 
synergistic coordination, entrepreneurship with its so-
cial and economic contributions, is not widely pursued. 
Instead of developing and implementing new ideas, local 
firms are inclined to produce known products and use 
established processes. With the exception of foreign 
nationals living in Panama, we observed that creativity, 
autonomy, independence and ability to take risks, were 
lacking in people’s assessment of their professional 
choices. Because trial and error are essential to innova-
tion and to the creation of new ideas (Audretsch & 
Thurik, 2000), we conclude that the culture of innova-
tion is yet to be developed in Panama. Efforts to en-
courage entrepreneurship among local students through 
business education and training may spur such activity.      
The current bioscience sector in Panama is very frag-
mented, with little interconnectivity and a few collabora-
tions between private companies and universities. 
Enhancing specific target areas of the bioscience sector 
through the establishment of “Centers of Excellence” 
would result in concentration of human resources and 
specialized equipment. Active international promotion 
of the potential capabilities of these areas of strengths 
would serve to initiate international academic collabora-
tions (OECD; Bologna, 2000), thus allowing for grant 
funding through international sources. In the area of 
commercialization, new product development and 
supply of services to business entities would lead to a 
further funding sustainability and exposure of scientists 
to for-profit firms. One specific area of opportunity ex-
ists in the growing presence of clinical trials in the re-
gion. Given the current health care environment in 
developed nations, drug trials are on the rise globally 
and increasing in Latin America (Shah, 2003; Getz, 
2006). Regional clinical trials address health concerns of 
the local population, thereby linking the expertise and 
interest of local scientists and physicians. Currently, the 
clinical research organizations present in Panama have a 
relatively high level of employment of locally trained 
personnel and as such contribute to the building of hu-
man resource capacity. Efforts to develop capacities 
related to clinical trials and linking them to local training 
programs would further facilitate concentration of local 
talent.  
In this report, we attempted to outline a model for ca-
pacity building in the bioscience sector for the country 
of Panama. The elements of infrastructure, human re-
sources, knowledge resources, and capital are being 
addressed as they represent the foundation for sustain-
able growth. We utilized the “Triple Helix” or govern-
ment-academia-industry model for enterprise formation 
(Etzkowitz, 2008), and applied it to the biosciences sec-
tor of Panama. Importantly, we find the involvement of 
foreign players to be critical for the development of a 
sector within a small market. Once formed, the in-
creased bioscience capacity will benefit from greater 
international academic collaborations, in recognition of 
mutually beneficial strengths. Foreign collaborations 
encompassing commercialization processes are likely to 
incorporate locally trained scientists and thus make the 
sector more sustainable. Efficient transfer of technolo-
gies from developed countries through access to specia-
lized equipment and foreign-trained scientists, such as 
seen in the ICBG program, will help establish strong 
research programs. The presence of companies involved 
in bioscience services and R&D will provide further im-
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petus for young talent to pursue study in the bios-
ciences. Taking into account all efforts to date, we con-
clude that Panama has actively begun to build on its 
strengths in the biosciences. Further efforts to coordi-
nate the interests of policy makers, academics, and 
commercial companies, together with foreign collabora-
tors will only accelerate this process. With concentra-
tion of resources in the areas of strengths and increased 
R&D expenditures, Panama could become a key regional 
player in the bioscience sector.  
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